Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coates, P. A.
Right arrow Articles by Owens, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coates, P. A.
Right arrow Articles by Owens, D. R.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 44, Issue 6 631-635, Copyright © 1995 by American Diabetes Association


ARTICLES

Comparison of estimates of insulin sensitivity from minimal model analysis of the insulin-modified frequently sampled intravenous glucose tolerance test and the isoglycemic hyperinsulinemic clamp in subjects with NIDDM

PA Coates, SD Luzio, P Brunel and DR Owens
Diabetes Research Unit, University of Wales College of Medicine, Cardiff, U.K.

Minimal model (MINMOD) analysis of the frequently sampled intravenous glucose tolerance test (FSIVGTT) is dependent on an adequate insulin response to the glucose load. As this is characteristically deficient in subjects with non-insulin-dependent diabetes mellitus (NIDDM), the technique has been modified by the use of an intravenous bolus of insulin. Previous validation of this modification in humans has relied on agreement between insulin sensitivity indexes (SI) estimated from tolbutamide- and insulin-modified tests and not on direct comparison with estimates derived from the isoglycemic glucose clamp. We have compared estimates of insulin sensitivity derived from minimal modeling of a 4-h insulin-modified FSIVGTT and the glucose clamp in subjects with NIDDM. Twelve subjects underwent an insulin-modified FSIVGTT and an isoglycemic hyperinsulinemic clamp in random order 2-4 weeks apart. Fasting plasma glucose (8.4 vs. 9.0 mmol/l) and immunoreactive insulin (IRI) concentrations (104.5 vs. 101.5 pmol/l) were not different between the 2 study days. SI(clamp) was derived from the steady-state glucose infusion rate during the 3rd h of the clamp, corrected for the ambient insulin and glucose concentrations. SI(ivgtt) was derived using MINMOD. SI(ivgtt) was 1.06 +/- 0.18 min-1.mU-1.ml x 10(4), and mean SI(clamp) was 4.97 +/- 0.69 l.min-1/pmol.l-1 x 10(4) (mean +/- SE). SI(ivgtt) was positively correlated with SI(clamp) (r = 0.73, P = 0.004) and negatively correlated with body mass index (r = -0.7, P = 0.005) and fasting IRI(ivgtt) (r = -0.64, P = 0.008). In summary, MINMOD analysis of the insulin-modified FSIVGTT provides a valid measure of insulin sensitivity in subjects with NIDDM.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
D. A. Elder, R. L. Prigeon, R. P. Wadwa, L. M. Dolan, and D. A. D'Alessio
{beta}-Cell Function, Insulin Sensitivity, and Glucose Tolerance in Obese Diabetic and Nondiabetic Adolescents and Young Adults
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 185 - 191.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. F. Saad, M. Rewers, J. Selby, G. Howard, S. Jinagouda, S. Fahmi, D. Zaccaro, R. N. Bergman, P. J. Savage, and S. M. Haffner
Insulin Resistance and Hypertension: The Insulin Resistance Atherosclerosis Study
Hypertension, June 1, 2004; 43(6): 1324 - 1331.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. I. Sivitz, S. M. Wayson, M. L. Bayless, L. F. Larson, C. Sinkey, R. S. Bar, and W. G. Haynes
Leptin and Body Fat in Type 2 Diabetes and Monodrug Therapy
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1543 - 1553.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Katz, S. S. Nambi, K. Mather, A. D. Baron, D. A. Follmann, G. Sullivan, and M. J. Quon
Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans
J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2402 - 2410.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
C. McDonald, A. Dunaif, and D. T. Finegood
Minimal-Model Estimates of Insulin Sensitivity Are Insensitive to Errors in Glucose Effectiveness
J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2504 - 2508.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Izumino, H. Sakamaki, M. Ishibashi, H. Takino, H. Yamasaki, Y. Yamaguchi, N. Chikuba, K. Matsumoto, S. Akazawa, K. Tokuyama, et al.
Troglitazone Ameliorates Insulin Resistance in Patients with Werner's Syndrome
J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2391 - 2395.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Taegtmeyer
Insulin Resistance and Atherosclerosis : Common Roots for Two Common Diseases?
Circulation, May 15, 1996; 93(10): 1777 - 1779.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1995 by the American Diabetes Association.